VKH
VNDA icon

Virtu KCG Holdings’s Vanda Pharmaceuticals VNDA Stock Holding History

Virtu KCG Holdings’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-27,978
Closed -$316K – 3969
2015
Q3 		$316K Buy
+27,978
New +$342K 0.01% 2031
2015
Q2 		– Sell
-19,760
Closed -$184K – 3792
2015
Q1 		$184K Buy
19,760
+7,069
+56% +$79.9K ﹤0.01% 2442
2014
Q4 		$182K Sell
12,691
-883
-7% -$10.4K ﹤0.01% 2933
2014
Q3 		$141K Buy
+13,574
New +$178K ﹤0.01% 3093
2013
Q4 		– Sell
-19,511
Closed -$214K – 4299
2013
Q3 		$214K Buy
+19,511
New +$208K ﹤0.01% 3031

Other funds holding VNDA

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu KCG Holdings's VNDA Position: Q4 2015 in Review

Virtu KCG Holdings sold out of Vanda Pharmaceuticals (VNDA) in Q4 2015, closing a stake of 27,978 shares — an estimated $316K sold.

Virtu KCG Holdings first reported a position in VNDA in Q3 2013 and held it in 5 quarters. The position peaked at $316K in Q3 2015. 117 funds tracked by Wall St. Rank hold VNDA as of Q4 2015.

  • Virtu KCG Holdings reported no remaining Vanda Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Virtu KCG Holdings sold 27,978 Vanda Pharmaceuticals shares in Q4 2015, an estimated $316K.
  • Virtu KCG Holdings first reported a position in Vanda Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Virtu KCG Holdings's Vanda Pharmaceuticals position peaked at $316K in Q3 2015.
  • 117 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2015.

Based on Virtu KCG Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.